Medium severity · published Jan 8, 2021
CVE-2020-27262
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability exists in the affected products that allow an attacker to…
5.4
CVSS
0.7%
EPSS
No
On KEV
Description
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability exists in the affected products that allow an attacker to inject arbitrary web script or HTML via the filename parameter to multiple update endpoints of the administrative web interface.
CVSS vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Attack vector
Network
Complexity
Low
Privileges
Low
User interaction
Required
Confidentiality
Low
Integrity
Low
Availability
None
Scope
Changed
Exploitation
Is it being used?
Exploit prediction (EPSS)0.7% · higher than 52% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
VS
Vital Signs Monitor Vc150 Firmware · Innokasmedical
before 1.7.15 · source: NVD
Affected product
VS
Vital Signs Monitor Vc150 Firmware
Innokasmedical
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2020-27262
CVE.org
https://www.cve.org/CVERecord?id=CVE-2020-27262
Third Party Advisory
https://us-cert.cisa.gov/ics/advisories/icsma-21-007-01
More from Vital Signs Monitor Vc150 Firmware
5.3
CVE-2020-27260
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers…